These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30686784)

  • 21. Super-Enhancer-Driven Transcriptional Dependencies in Cancer.
    Sengupta S; George RE
    Trends Cancer; 2017 Apr; 3(4):269-281. PubMed ID: 28718439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
    Jia Q; Chen S; Tan Y; Li Y; Tang F
    Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DEEPSEN: a convolutional neural network based method for super-enhancer prediction.
    Bu H; Hao J; Gan Y; Zhou S; Guan J
    BMC Bioinformatics; 2019 Dec; 20(Suppl 15):598. PubMed ID: 31874597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
    Okabe A; Kaneda A
    Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Super-enhancers: A new frontier for glioma treatment.
    Cheng M; Zhang ZW; Ji XH; Xu Y; Bian E; Zhao B
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188353. PubMed ID: 32112817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiology of super-enhancer reprogramming and activation in cancer.
    Zhou RW; Parsons RE
    Epigenetics Chromatin; 2023 Jul; 16(1):29. PubMed ID: 37415185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
    Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
    Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiated super-enhancers in lung cancer cells.
    Li X; Lu C; Lu Q; Li C; Zhu J; Zhao T; Chen H; Jin H
    Sci China Life Sci; 2019 Sep; 62(9):1218-1228. PubMed ID: 30635833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Super-enhancer omics in stem cell.
    Ma H; Qu J; Pang Z; Luo J; Yan M; Xu W; Zhuang H; Liu L; Qu Q
    Mol Cancer; 2024 Aug; 23(1):153. PubMed ID: 39090713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC.
    Bao J; Li M; Liang S; Yang Y; Wu J; Zou Q; Fang S; Chen S; Guo L
    BMC Med Genomics; 2019 May; 12(1):67. PubMed ID: 31118037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SEA version 3.0: a comprehensive extension and update of the Super-Enhancer archive.
    Chen C; Zhou D; Gu Y; Wang C; Zhang M; Lin X; Xing J; Wang H; Zhang Y
    Nucleic Acids Res; 2020 Jan; 48(D1):D198-D203. PubMed ID: 31667506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status.
    Vasileva AV; Gladkova MG; Ashniev GA; Osintseva ED; Orlov AV; Kravchuk EV; Boldyreva AV; Burenin AG; Nikitin PI; Orlova NN
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.
    Hah N; Benner C; Chong LW; Yu RT; Downes M; Evans RM
    Proc Natl Acad Sci U S A; 2015 Jan; 112(3):E297-302. PubMed ID: 25564661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Validation and Prediction of Super-Enhancers: Advances and Challenges.
    Kravchuk EV; Ashniev GA; Gladkova MG; Orlov AV; Vasileva AV; Boldyreva AV; Burenin AG; Skirda AM; Nikitin PI; Orlova NN
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analyses of super-enhancers reveal conserved elements in vertebrate genomes.
    Pérez-Rico YA; Boeva V; Mallory AC; Bitetti A; Majello S; Barillot E; Shkumatava A
    Genome Res; 2017 Feb; 27(2):259-268. PubMed ID: 27965291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromatin Interactions and Regulatory Elements in Cancer: From Bench to Bedside.
    See YX; Wang BZ; Fullwood MJ
    Trends Genet; 2019 Feb; 35(2):145-158. PubMed ID: 30577989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Super-Enhancer-Mediated RNA Processing Revealed by Integrative MicroRNA Network Analysis.
    Suzuki HI; Young RA; Sharp PA
    Cell; 2017 Mar; 168(6):1000-1014.e15. PubMed ID: 28283057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Super-enhancer lncs to cardiovascular development and disease.
    Ounzain S; Pedrazzini T
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1953-60. PubMed ID: 26620798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting super enhancers for liver disease: a review.
    Yang Z; Liu Y; Cheng Q; Chen T
    PeerJ; 2023; 11():e14780. PubMed ID: 36726725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Typical Enhancers, Super-Enhancers, and Cancers.
    Koutsi MA; Pouliou M; Champezou L; Vatsellas G; Giannopoulou AI; Piperi C; Agelopoulos M
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.